Recordkeeping fees per participant
not reported
Not reported on this filing.
Employers › MP Biomedicals
MP Biomedicals 401(k)
- Manufacturing
- Solon, OH
- EIN 65-1193911
- 1 plan with Schedule H financials
- Plan year 2024
- MP Biomedicals, Inc.
- SEC registrant MP Biomedicals LLC
Administrative expenses excluding investment management, per participant · MP Biomedicals, Inc. Retirement Savings Plan · plan year 2024
$330.41
Higher than 89% of the 24,371 plans $10 to 50M that report it.
Source
= $54,188 / 164
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251015085943NAL0004393537001, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015085943NAL0004393537001, received 2025-10-15
Percentiles compare this plan with the Schedule H plans $10 to 50M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-10-15.
Cost and contributions
Administrative expenses per participant
$409.39
Higher than 86% of the 25,098 plans $10 to 50M that report it.
Source
= $67,140 / 164
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251015085943NAL0004393537001, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015085943NAL0004393537001, received 2025-10-15
Administrative expenses as a share of assets
0.504%
Higher than 82% of the 25,132 plans $10 to 50M that report it.
Source
= $67,140 / $13,332,514
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251015085943NAL0004393537001, received 2025-10-15
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251015085943NAL0004393537001, received 2025-10-15
Employer contributions per participant
$1,062
Higher than 20% of the 24,050 plans $10 to 50M that report it.
Source
= $174,237 / 164
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251015085943NAL0004393537001, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015085943NAL0004393537001, received 2025-10-15
Employer share of total contributions
16.8%
Higher than 17% of the 24,084 plans $10 to 50M that report it.
Source
= $174,237 / $1,036,436
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251015085943NAL0004393537001, received 2025-10-15
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251015085943NAL0004393537001, received 2025-10-15
Plan terms, as stated in MP Biomedicals, Inc.'s SEC filings
Plan terms are not published in public filings.
Plan features
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2S pre-approved plan document · 2T default investment (QDIA) · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20251015085943NAL0004393537001, received 2025-10-15
Full record, MP Biomedicals, Inc. Retirement Savings Plan
| Field | Value | Source |
|---|---|---|
| Plan sponsor | MP BIOMEDICALS, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Plan name | MP BIOMEDICALS, INC. RETIREMENT SAVINGS PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Sponsor EIN / plan number | 65-1193911 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Sponsor location | SOLON, OH | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Industry (business code) | 325100, Manufacturing | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Filing received | 2025-10-15 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Participants, beginning of year | 202 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Active participants | 117 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Participants, end of year | 184 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Participants with an account balance | 164 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Total assets, beginning of year | $12,375,127 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Total assets, end of year | $13,332,514 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Net assets, end of year | $13,332,514 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Total income | $2,571,653 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Net income | $957,387 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Employer contributions | $174,237 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Participant contributions | $619,350 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Other contributions (incl. rollovers) | $242,849 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Total contributions | $1,036,436 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Benefit payments | $1,547,126 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Total expenses (incl. benefit payments) | $1,614,266 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Total administrative expenses | $67,140 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Contract administrator fees | $34,759 | Schedule H, line 2i(2); CONTRACT_ADMIN_FEES_AMT pos 106; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Investment advisory and management fees | $12,952 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Administrative expenses excluding investment management | $54,188 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Held in common/collective trusts | $1,308,203 | Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Held in mutual funds | $6,651,733 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20251015085943NAL0004393537001, received 2025-10-15 |
| Independent auditor | MEADEN & MOORE, LTD | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20251015085943NAL0004393537001, received 2025-10-15 |
Position = column in the DOL layout for form year 2024. Filing 20251015085943NAL0004393537001, received 2025-10-15.
Service providers paid directly by the plan
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| PRINCIPAL LIFE INSURANCE COMPANYrecordkeeper | CONTRACT ADMINISTRATOR | 13 Contract administrator; 37 Participant loan processing; 50 Direct payment from the plan; 64 Recordkeeping fees | $34,759 | yes |
| MERRILL LYNCH PIERCE FENNER & SMITH | CONSULTANT | 17 Consulting (pension); 27 Investment advisory (plan); 50 Direct payment from the plan | $32,369 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20251015085943NAL0004393537001, received 2025-10-15.
What changed since the 2023 plan year
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $12,375,127 | $13,332,514 | 7.7% |
| Participants with a balance | 181 | 164 | -9.4% |
| Administrative expenses | $62,940 | $67,140 | 6.7% |
| Recordkeeping fees per participant | not reported | not reported | |
| Employer contributions | $193,780 | $174,237 | -10.1% |
Prior filing 20241014121347NAL0013259891001, received 2024-10-14; the plan years are contiguous.
Alerts, claims and corrections
Sponsor name as filed: MP BIOMEDICALS, INC.; SEC registrant: MP BIOMEDICALS LLC (CIK 1539205, matched by EIN).